Pharmaceuticals - Community Register

  

Community register of medicinal products for human use


AUTHORISED  

Product information

Invented name: Memantine Accord   

   This product is authorized under a different brandname in the EU in the folowing languages:
   - Мемантин Accord (BG)
   - Memantin Accord (DA)
   - Memantin Accord (DE)
   - Memantina Accord (ES)
   - MEMANTINE ACCORD (FR)
   - Memantin Accord (HR)
   - Memantina Accord (IT)
   - Memantina Accord (PT)
   - Memantin Accord (SL)
Auth. number : EU/1/13/880
INN : memantine
ATC: Anatomical main group: N - Nervous system
Therapeutic subgroup: N06 - Psychoanaleptics
Pharmacological subgroup: N06D - Anti-dementia drugs
Chemical subgroup: N06DX - Other anti-dementia drugs
Chemical substance: N06DX01 - Memantine
(See WHO ATC Index)
Indication: Treatment of patients with moderate to severe Alzheimer's disease.
Marketing Authorisation Holder: Accord Healthcare Limited
Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF, United Kingdom

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/12/2013 Centralised - Authorisation EMEA/H/C/2766 (2013)8896 of 04/12/2013
31/03/2014 Centralised - Variation EMEA/H/C/2766/IB/1/G